|
Home : Unsafe Drugs : Avandia : Newsfeeds : Glaxo Diabetes Candidate Disappoints Glaxo Diabetes Candidate Disappoints
Meanwhile, Tolerx has the option to co-promote otelixizumab with Glaxo for type I diabetes in the US. We note that Glaxo’s diabetes franchise (Avandia products) has been under pressure over the past few years. In Feb 2011, the company announced a ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




